Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

77 study records (showing up to 30 per record type)

• Registered trial NCT05800886 Completed (results not assessed here)
  The Effect of Early Mobilization and Fluid Consumption on Bowel Movements After Cholecystectomy
  Condition or outcome area: Cholelithiases|Nursing Caries|Perioperative Complication|Bowel Ileus
  2020-01-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT05861206 Completed (results not assessed here)
  Efficacy of Green and White Tea Extract Mouthwashes in the Management of Plaque-induced Gingivitis: A Clinical and Biochemical Study
  Condition or outcome area: Gingivitis; Chronic|Oxidative Stress|Inflammation
  2020-09-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT05681325 Not completed: Active Not Recruiting
  Evaluation of Antioxidant and Anti-inflammatory Effect of Matcha Tea Intake on Periodontal Health
  Condition or outcome area: Gingival Disease
  2022-01-25 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT05841589 Completed (results not assessed here)
  Evaluation of Antimicrobial Efficacy of Green Tea, Garlic With Lime, Pomegranate Extract and Chlorhexidine Mouth Rinses in a Group of Egyptian Children (In-Vivo Study)
  Condition or outcome area: Dental Caries
  2018-02-21 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT05882942 Completed (results not assessed here)
  Matcha Green Tea Effects at Rest and During Moderate-intensity Exercise in Females
  Condition or outcome area: No Condition
  2023-03-03 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT02015312 Phase 2 Completed (results not assessed here)
  A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)
  Condition or outcome area: Light Chain (AL) Amyloidosis|Cardiac Involvement
  2013-04 · Subject: (-)-Epigallocatechin-3-Gallate; Epigallocatechin gallate; tea polyphenols; Gallic catechin; epigallocatechin 3-gallate(egcg); (-)-epigallocatechin 3-o-gallate ; epigallocatechin gallate; epigallocatechin 3-gallate; galloyl-l-epigallocatechol; KBio2_000796 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01032031 Completed (results not assessed here)
  The Effect of Green Tea and Vitamin C on Skin Health
  Condition or outcome area: Skin Cancer
  2009-03 · Subject: L-Ascorbic Acid; Ascorbic acid; l-ascorbic acid · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00867555 Completed (results not assessed here)
  Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation
  Condition or outcome area: Obesity|Type 2 Diabetes Mellitus
  2008-10 · Subject: (-)-Epigallocatechin-3-Gallate; Epigallocatechin gallate; tea polyphenols; Gallic catechin; epigallocatechin 3-gallate(egcg); (-)-epigallocatechin 3-o-gallate ; epigallocatechin gallate; epigallocatechin 3-gallate; galloyl-l-epigallocatechol; KBio2_000796 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00768118 Completed (results not assessed here)
  A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
  Condition or outcome area: Healthy, no Evidence of Disease
  2008-04 · Subject: Curcumin; (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one; C10443; BSPBio_003590; NCGC00095321-01; KBio3_003004; InChI=1/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-13,22,24-25H,1-2H3/b7-3+,8-4+,16-13; curcumin ; diferuloylmethane; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01912820 Phase 1 Completed (results not assessed here)
  Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
  Condition or outcome area: Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer
  2014-01-01 · Subject: Quercetin; Sophoretin; Meletin; Quercetine; 117-39-5; Xanthaurine; Quercetol · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01018615 Phase 1 Completed (results not assessed here)
  Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
  Condition or outcome area: Chronic Hepatitis C|Oxidative Stress
  2009-11 · Subject: Silymarin; 2-[2R,3R-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2R,3R-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one; AC-20318; AKOS015965311; silymarin · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01105338 Phase 2 / Phase 3 Completed (results not assessed here)
  Lycopene or Green Tea for Men at Risk of Prostate Cancer
  Condition or outcome area: Prostate Cancer
  2009-08 · Subject: Lycopene; all-trans-Lycopene; Lycopene all-trans-; C05432; Spectrum4_001998; KBio2_002146; Lycopene, all-trans- (8CI); BSPBio_003389; (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene; trans-Lycopene · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT05364008 Phase 3 Not completed: Recruiting
  FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea
  Condition or outcome area: Leiomyoma, Uterine
  2023-01-05 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT05181176 Not completed: Unknown
  Effect of Coffee and Tea Consumption on Adolescent Weight Control
  Condition or outcome area: Body Weight
  2021-01-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT05048628 Completed (results not assessed here)
  The Effect of Ice, Green Tea and Arnica Montana Application on Post-Operative Intubation Related Sore Throat and Hoarseness
  Condition or outcome area: Sore Throat|Hoarseness
  2021-06-14 · Subject: Shan Jin Che; 山金车; Mountain Tobacco; Arnica Montana · open the herb record · ClinicalTrials.gov
• Registered trial NCT00003367 Phase 3 Completed (results not assessed here)
  Diet and PSA Levels in Patients With Prostate Cancer
  Condition or outcome area: Prostate Cancer
  1998-04 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT00611416 Completed (results not assessed here)
  The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism
  Condition or outcome area: Obesity
  2005-11 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT02719860 Phase 2 Completed (results not assessed here)
  High Tea Consumption on Smoking Related Oxidative Stress
  Condition or outcome area: Lung Cancer Prevention
  2003-09 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT01882283 Completed (results not assessed here)
  Effects of Black Tea Intake on Serum Lipids
  Condition or outcome area: Hypercholesterolemia
  2002-04 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT02545244 Phase 3 Completed (results not assessed here)
  Effectiveness of Black Tea Mouthwash on Plaque Formation
  Condition or outcome area: Gingivitis
  2015-02 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT02777853 Completed (results not assessed here)
  The Effect of Tea on Vascular Function and Insulin Sensitivity
  Condition or outcome area: Insulin Resistance
  2016-05 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT02779361 Phase 1 Completed (results not assessed here)
  Effect of Tea Consumption on Steroid Profile in Healthy Volunteers
  Condition or outcome area: Healthy Volunteers|Doping in Sports
  2016-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT00685516 Completed (results not assessed here)
  Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery
  Condition or outcome area: Prostate Cancer
  2007-09-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT01912820 Phase 1 Completed (results not assessed here)
  Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
  Condition or outcome area: Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer
  2014-01-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT00944827 Phase 2 Completed (results not assessed here)
  Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia
  Condition or outcome area: Hypercholesterolemia
  2007-09 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT01490008 Phase 1 Completed (results not assessed here)
  Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers
  Condition or outcome area: Anogenital Warts
  2011-12 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT00363805 Phase 2 Completed (results not assessed here)
  Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
  Condition or outcome area: Lung Cancer Prevention
  2004-05 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT00003197 Phase 1 Completed (results not assessed here)
  Green Tea Extract in Treating Patients With Advanced Solid Tumors
  Condition or outcome area: Unspecified Adult Solid Tumor, Protocol Specific
  1997-12 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT01248143 Phase 2 / Phase 3 Completed (results not assessed here)
  Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases
  Condition or outcome area: Assess the Effect of Green Tea on Diabetes|Assess the Effect of Fermented Papaya Pretration on Diabetes|Effects of Green Tea and FPP on C-reactive Proteins|Effects of Green Tea and FPP of Lipid Profiles in Diabetes|Effect of Green Tea and FPP on Atheroma Formation
  2010-11 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT00721890 Phase 2 Completed (results not assessed here)
  Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
  Condition or outcome area: Ovarian Carcinoma
  2008-06 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42023489576 Registered protocol, no results here: Review Ongoing
  The effect of green tea extract supplementation on blood Creatine kinase concentration in adults: A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: In this study, the effect of green tea supplementation on creatine kinase will be investigated
  2023-12-15 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42023484787 Registered protocol, no results here: Review Ongoing
  The association between green tea or green tea extracts and the risk of cancer: A systematic review with meta-analysis
  Condition or outcome area: The world is facing an enormous burden of cancer disease. Continuing increases in incidence in populous low- and middle-income countries and high incidence in most developed countries have led to a further increase in the global health threat of cancer, which will remain a major public health problem for a long time. Studies by the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) have shown that the number of cancer cases and deaths worldwide is increasin
  2023-12-03 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42023451100 Registered protocol, no results here: Review Ongoing
  Tea consumption and health outcomes: an umbrella review
  Condition or outcome area: Meta-analyses involving any health outcomes were included if the exposure was tea consumption irrespective of the ethnic factors, gender, location or settings of participants.
  2023-08-14 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42023437520 Registered protocol, no results here: Review Ongoing
  Effectiveness of caffeine or green tea co-ingestion with exercise training on weight control and metabolic measures in overweight and obese individuals: A systematic review and meta-analysis of randomized trials
  Condition or outcome area: overweight and obese individuals with body mas index of > 25 kg/m2 undergoing supervised exercise training with caffeine or green tea ingestion.
  2023-07-04 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42023481625 Registered protocol, no results here: Review Ongoing
  Impact of Herbal Supplements on Liver Enzyme Levels: A Systematic Review and Meta-analysis
  Condition or outcome area: Hepatic disease, Gastroenterology, treatment, Prevention
  2023-11-20 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42023424727 Registered protocol, no results here: Review Ongoing
  Effect of herbal medicine in the healing process of non-infected human skin wounds
  Condition or outcome area: Herbal medicine interventions for wound healing, investigate the effect and efficacy of medicinal plants on the healing process (recovery time, infection prevention, erythema and redness reduction, pain and itchiness alleviation, discharge and bleeding depletion, and moisture retention) of dermatic non-infectious injuries due to numerous causative factors.
  2023-05-19 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42023486263 Registered protocol, no results here: Review Ongoing
  Unfermented Tea (Camellia sinensis) and Its Components on Age, Stress, or Fatigue-Related Cognitive Decline or Dementia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
  Condition or outcome area: Dementia is a growing severe problem among the world, especially in elderly. According to the World Health Organization (WHO), 55 million people were having dementia in 2020. The amount was expected to grow to 139 million people in 2050. In Taiwan, the prevalence of dementia in people older than 65 was 7.86%. Dementia is related to a series of cognitive function decline, including attention, memory, executive function, reaction time, and so on. Mild cognitive impairment is developed from preclin
  2023-12-12 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42018104792 Registered protocol, no results here: Review Completed published
  The effects of the unique green tea amino acid L-theanine on the stress response and anxiety in human clinical trials – a systematic review of randomised controlled trials
  Condition or outcome area: The health-promoting properties of green tea are well established and it is consumed in abundance in some of the most densely populated countries in the world such as China and Japan. One of the water-soluble non-proteinogenic amino acids found in green tea, L-theanine, is responsible for the unique ‘umami’ taste associated with green tea consumption. Several in vitro studies have described the anti-tumour activity of L-theanine, while human trials have explored its potential cholesterol-lowerin
  2018-07-27 · Subject: Theanine; L-Theanine; 3081-61-6; N-Ethyl-L-glutamine; Theanin; Suntheanine; (S)-2-Amino-5-(ethylamino)-5-oxopentanoic acid; N5-Ethyl-L-glutamine; CCRIS 7326; C7H14N2O3 · open the ingredient record
• Systematic review registration CRD42023391478 Registered protocol, no results here: Review Ongoing
  Effect of epigallocatechin gallate on adult blood lipids, blood pressure and obesity: a systematic evaluation and meta-analysis
  Condition or outcome area: Obesity, hypertension and hyperlipidemia are high risk factors of many diseases and are major public health events in the world. Green tea, green tea extract, catechin and epigallocatechin gallate have good effects on many diseases. The purpose of this systematic evaluation is to evaluate the effect of epigallocatechin gallate on obesity, blood pressure and blood lipids.
  2023-01-23 · Subject: L-epigallocatechin; Epigallocatechin; (-)-Epigallocatechin; 970-74-1; Epigallocatechol; epi-Gallocatechin; Antiscurvy factor C2; (-)-Epigallocatechol; l-Epigallocatechol; Galloepicatechin · open the ingredient record
• Systematic review registration CRD42023391478 Registered protocol, no results here: Review Ongoing
  Effect of epigallocatechin gallate on adult blood lipids, blood pressure and obesity: a systematic evaluation and meta-analysis
  Condition or outcome area: Obesity, hypertension and hyperlipidemia are high risk factors of many diseases and are major public health events in the world. Green tea, green tea extract, catechin and epigallocatechin gallate have good effects on many diseases. The purpose of this systematic evaluation is to evaluate the effect of epigallocatechin gallate on obesity, blood pressure and blood lipids.
  2023-01-23 · Subject: Epigallocatechin; (-)-Epigallocatechin; 970-74-1; Epigallocatechol; L-Epigallocatechin; epi-Gallocatechin; Antiscurvy factor C2; (-)-Epigallocatechol; l-Epigallocatechol; Galloepicatechin · open the ingredient record
• Systematic review registration CRD42022360316 Registered protocol, no results here: Review Ongoing
  Green tea consumption and the risk of stroke: a meta-analysis of cohort studies
  Condition or outcome area: stroke
  2022-09-25 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42022357687 Registered protocol, no results here: Review Ongoing
  Green tea consumption and the risk of coronary heart disease: a systematic review and meta-analysis of cohort studies
  Condition or outcome area: coronary heart disease
  2022-09-13 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42022348069 Registered protocol, no results here: Review Ongoing
  Association between tea consumption and prevention of coronary heart disease: a meta-analysis of epidemiological studies
  Condition or outcome area: Coronary atherosclerotic sex heart disease is coronary artery blood vessel produces atherosclerotic pathological changes and causes vascular cavity narrow or block, cause myocardial ischemia, anoxic or necrotic and cause heart disease, often called coronary heart disease. Coronary heart disease (CHD) tends to occur in people with hypertension and hyperlipidemia and has become one of the important causes of disease burden in developed countries and some developing countries. Its high morbidity, h
  2022-08-02 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42022320345 Registered protocol, no results here: Review Ongoing
  Effect of Green Tea supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis
  Condition or outcome area: Metabolic syndrome factors is a broad term referred to several aspects of human health including inflammatory markers.
  2022-04-25 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42021281763 Registered protocol, no results here: Review Ongoing
  Green tea consumption reduces the incidence of postoperative intestinal obstruction: a meta-analysis
  Condition or outcome area: Postoperative ileus (POI) is a temporary suppression of propulsive bowel activity manifested by anorexia, nausea, vomiting, lack of bowel sounds, and absence of bowel movements; the incidence of POI has been reported to be between 10% and 30%.The pathogenesis of POI is multifactorial, and typically, the recovery time of intestinal function after surgery is 24-72 hours. Surgical inflammatory response, opioid administration, electrolyte abnormalities and inhibition of gastrointestinal activity by
  2021-10-30 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42021276257 Registered protocol, no results here: Review Ongoing
  Relationship between green tea consumption and the risk of colorectal cancer: A systematic review and meta-analysis
  Condition or outcome area: Case-control, and cohort studies
  2021-10-01 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42021257667 Registered protocol, no results here: Review Ongoing
  The effect of green tea on blood pressure: A systematic review and meta-analysis of randomized clinical trials
  Condition or outcome area: Hypertension is a leading cause of death, and a major risk factor for cardiovascular disease. Its global prevalence varies worldwide from as low as 3.4% to as high as 72.5%. Although over 90% of hypertensive cases are idiopathic , dietary and lifestyle factors are major risk factors associated with its increasing incidence. Many different dietary supplements are currently marketed for the management of hypertension, but the evidence for effectiveness is mixed . One such supplement thought to hav
  2021-06-27 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42021253230 Registered protocol, no results here: Review Completed published
  The effect of green tea intake on cardiovascular risk factors: A overview of systematic reviews and meta-meta-analysis
  Condition or outcome area: The primary outcomes were cardiovascular risk factors as follows: - Glycemic indicators (fasting blood sugar, fasting insulin, HOMA, HbA1c) - Lipid profile (triglyceride, total cholesterol, LDL, HDL) - Blood pressure (systolic, diastolic) - Anthropometric measurements (weight, BMI, Waist circumference)
  2021-07-11 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42021248287 Registered protocol, no results here: Review Ongoing
  A systematic review and meta-analysis of the green tea effects on anthropomethric parameters of PCOS patients
  Condition or outcome area: Women with polycystic ovary syndrome
  2021-05-10 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42021226296 Registered protocol, no results here: Review Completed published
  Effects of green tea on women with polycystic ovary syndrome: Systematic Review
  Condition or outcome area: The polycystic ovary syndrome (PCOS) is one of the main pathologies that affect women of reproductive age worldwide. The syndrome is characterized by heterogeneous endocrine dysfunction with hyperandrogenism, polycystic ovaries and ovulatory dysfunction as main symptoms. As a result of the intensification of these symptoms, women affected by PCOS have a greater tendency to accumulation of abdominal fat, development of metabolic dysfunction, insulin resistance and chronic inflammatory processes.
  2021-01-14 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42020216149 Registered protocol, no results here: Review Ongoing
  The effect of green tea on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials
  Condition or outcome area: Prostate cancer (PCa) is the major cause of cancer related mortality among men, with a globally higher incidence and wide geographical differences.Beside histological assessment, as a diagnostic method, prostate specific antigen (PSA) levels have been considered for screening of PCa in early stages.Plasma level of PSA is also used for assessing clinical risk, follow ups, and risk classification of patients with PCa. Preventive strategies such as lifestyle modifications and use of chemo-preventiv
  2020-11-26 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42020168524 Registered protocol, no results here: Review Ongoing
  The efficacy and safety of green tea extract for the prevention of colorectal adenomas: a systematic review and meta-analysis.
  Condition or outcome area: Removal or prevention of colorectal adenomas can reduce colorectal cancer incidence. NSAIDs such as low dose aspirin have been shown to reduce the incidence of colorectal adenomas, but increase the risk of gastrointestinal and genitourinary bleeding. NSAIDs are not recommended for chemoprevention in the general population. Compounds with efficacy in preventing colorectal adenomas, but low or no side effects would be desirable. Green tea polyphenols have chemopreventive and possibly cancer chemot
  2020-04-28 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42019144998 Registered protocol, no results here: Review Completed published
  Effect of green tea on liver enzymes: a systematic review and meta-analysis
  Condition or outcome area: Fatty liver, diabetes and any other conditions with high level of liver enzymes
  2019-10-30 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42019140690 Registered protocol, no results here: Review Ongoing
  Effect of turmeric and green tea on the cardiometabolic risk. Systematic review
  Condition or outcome area: Cardiometabolic risk, as a prevalent condition to aterosclerotic cardiovascular diseases and type 2 diabetes.
  2019-08-20 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42019135161 Registered protocol, no results here: Review Discontinued (No articles were obtained within the eligibility criteria.)
  Effects of green tea consumption on postmenopausal osteoporosis: a systematic review and meta-analysis.
  Condition or outcome area: Postmenopausal osteoporosis . Aging in women.
  2019-07-16 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42019130629 Registered protocol, no results here: Review Ongoing
  Camellia sinensis (green tea) for managing caries and periodontitis: systematic review and meta-analysis
  Condition or outcome area: Camellia sinensis (green tea) might be beneficial to prevent or treat oral diseases like caries, gingivitis or periodontitis, which are associated with a shift in the bacterial biofilm composition and activity as well as subsequent host reactions. Clinically, alterations of surrogate markers like bacterial numbers have been used to argue for the benefits of green tea therapy.
  2019-07-12 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42017081750 Registered protocol, no results here: Review Ongoing
  Green tea as a safe alternative approach for non-alcoholic fatty liver treatment: a systematic review and meta-analysis
  Condition or outcome area: Patients who suffer from Non-alcoholic fatty liver disease (NAFLD).
  2017-12-15 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42017078410 Registered protocol, no results here: Review Ongoing
  The effect of green tea consumption on glycaemic response in humans
  Condition or outcome area: Diabetes, prediabetes and general health
  2017-11-16 · Subject: Wu Long Cha; 乌龙茶; Oolong Tea; Camellia Sinensis Var. Viridis · open the herb record
• Systematic review registration CRD42017078410 Registered protocol, no results here: Review Ongoing
  The effect of green tea consumption on glycaemic response in humans
  Condition or outcome area: Diabetes, prediabetes and general health
  2017-11-16 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Systematic review registration CRD42017058194 Registered protocol, no results here: Review Ongoing
  The effect of green tea on plasma leptin and ghrelin levels: a systematic review and meta-analysis of randomized controlled clinical trials
  Condition or outcome area: Obesity is the most common health problem worldwide. More than 50% of Americans are overweight. Obesity increases the risk of many chronic diseases such as diabetes mellitus, cancer, osteoarthritis, cardiovascular disease, and hyperlipidemia. Increased energy intake or decreased energy expenditure is the main cause for the development of obesity; therefore, reducing energy intake and sustaining energy expenditure is a solution to lose weight. Losing 5–10% of initial body weight leads to benefic
  2017-02-27 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record
• Publication PMID 35691596 Research model: Clinical & Animal Experiment
  Green tea catechin EGCG could prevent obesity-related precocious puberty through NKB/NK3R signaling pathway
  Condition or outcome area: precocious puberty; obesity; obese
  J Nutr Biochem · 2022 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.jnutbio.2022.109085
• Publication PMID 35618244 Research model: Animal Experiment
  Long-term consumption of green tea EGCG enhances murine health span by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis, and immunosenescence
  Condition or outcome area: gut dysbiosis
  J Nutr Biochem · 2022 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.jnutbio.2022.109068
• Publication PMID 33069855 Research model: Animal Experiment
  Green tea derivative (-)-epigallocatechin-3-gallate (EGCG) confers protection against ionizing radiation-induced intestinal epithelial cell death both in vitro and in vivo
  Condition or outcome area: ferroptosis; oxidative stress-related diseases; intestinal mucosal injury; Radiation-induced intestinal injury
  Free Radic Biol Med · 2020 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.freeradbiomed.2020.10.012
• Publication PMID 36228975 Research model: Animal & Cell Experiment
  Green tea extract exhibits antidiabetic effects partly through regulating dipeptidyl peptidase-4 expression in adipose tissue
  J Nutr Biochem · 2022 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.1016/j.jnutbio.2022.109173
• Publication PMID 35618244 Research model: Animal Experiment
  Long-term consumption of green tea EGCG enhances murine health span by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis, and immunosenescence
  Condition or outcome area: gut dysbiosis
  J Nutr Biochem · 2022 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.1016/j.jnutbio.2022.109068
• Publication PMID 35134507 Research model: Animal & Cell Experiment
  Green tea extract increases adiponectin and PPAR α levels to improve hepatic steatosis
  Condition or outcome area: obesity; hepatic steatosis; steatosis; non-alcoholic fatty liver disease
  J Nutr Biochem · 2022 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.1016/j.jnutbio.2022.108957
• Publication PMID 34607205 Research model: Animal Experiment
  Potential role of green tea extract and epigallocatechin gallate in preventing bisphenol A-induced metabolic disorders in rats: Biochemical and molecular evidence
  Condition or outcome area: metabolic disorders
  Phytomedicine · 2021 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.1016/j.phymed.2021.153754
• Publication PMID 32993022 Research model: Animal Experiment
  Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes
  Condition or outcome area: mitochondrial dysfunction; cardiomyopathies
  Nutrients · 2020 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.3390/nu12102949
• Publication PMID 32480000 Research model: Animal Experiment
  Green tea improves the metabolism of peripheral tissues in β3-adrenergic receptor-knockout mice
  Condition or outcome area: obese
  Pharmacol Res · 2020 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.1016/j.phrs.2020.104956
• Publication PMID 32458968 Research model: Animal Experiment
  Green tea polyphenols ameliorate metabolic abnormalities and insulin resistance by enhancing insulin signalling in skeletal muscle of Zucker fatty rats
  Condition or outcome area: obesity
  Clin Sci (Lond) · 2020 · Subject: Lv Cha; 绿茶; Green Tea; Folium Camelliae Sinensis · open the herb record · DOI 10.1042/CS20200107
• Publication PMID 20546800 Research model: Animal Experiment
  Oral pretreatment with a green tea polyphenol for cardioprotection against ischemia-reperfusion injury in an isolated rat heart model
  J Thorac Cardiovasc Surg · 2011 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.jtcvs.2010.04.016
• Publication PMID 21177307 Research model: Animal Experiment
  Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer
  FASEB J · 2011 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1096/fj.10-167924
• Publication PMID 21544063 Research model: Animal Experiment
  The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis
  Condition or outcome area: Glomerulonephritis
  Kidney Int · 2011 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1038/ki.2011.121
• Publication PMID 21821246 Research model: Animal Experiment
  Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo
  Fertil Steril · 2011 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.fertnstert.2011.07.008
• Publication PMID 22050122 Research model: Cell Experiment
  The effect of green tea polyphenols on macrophage migration inhibitory factor-associated steroid resistance
  Br J Dermatol · 2012 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1111/j.1365-2133.2011.10720.x
• Publication PMID 29024813 Research model: Cell Experiment
  A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer
  Cancer Lett · 2018 · Subject: (-)-epigallocatechin-3-gallate; Epigallocatechin Gallate; (-)-Epigallocatechin gallate; EGCG; 989-51-5; Epigallocatechin gallate; Epigallocatechin 3-gallate; Tea catechin; Epigallocatechin-3-gallate; Teavigo · open the ingredient record · DOI 10.1016/j.canlet.2017.09.054
• Publication PMID 32032735 Research model: Clinical & Animal Experiment
  The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
  Condition or outcome area: autistic II seizures II CDKL5 deficiency disorder
  Neurobiol Dis · 2020 · Subject: Harmine; 442-51-3; 7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole; Banisterine; Telepathine; Leucoharmine; Yageine; Yajeine; 9H-Pyrido[3,4-b]indole, 7-methoxy-1-methyl-; 7-Methoxy-1-methyl-9H-beta-carboline · open the ingredient record · DOI 10.1016/j.nbd.2020.104791